T-bet enhances the encephalitogenicity of myelin-reactive CD4 + T cells, however its mechanism of action is unknown. In this study we show that T-bet confers a competitive advantage for the accumulation of IL-23 conditioned Th17 effector cells in the central nervous system (CNS). Impaired migration of T-bet deficient Th17 cells to the CNS is associated with altered expression of adhesion molecules and chemokine receptors on their cell surface. Our data suggest that therapeutic targeting of T-bet in individuals with Th17-mediated autoimmune demyelinating disease may inhibit inflammatory infiltration of the CNS and, hence, clinical exacerbations.
Introduction
Experimental autoimmune encephalomyelitis (EAE) is a multifocal demyelinating disease of the central nervous system (CNS) that has clinical and histopathological similarities to multiple sclerosis (MS). It can be induced by the adoptive transfer of myelin antigen-primed and reactivated CD4 + T cells into naïve syngeneic hosts. Reactivity of donor T cells against myelin antigens is necessary, but not sufficient, for EAE induction. The properties that myelin-reactive T cells must acquire during differentiation to become pathogenic is the subject of ongoing research.
T-bet (encoded by Tbx21), a leukocyte-specific member of the T-box family of transcription factors, has been identified as one of the noncognate, T cell intrinsic molecules that enhance encephalitogenicity. As a master regulator of Th1 cell differentiation, it induces activation of the IFNγ gene and upregulation of the IL-12 receptor β2 chain, while suppressing Th2 and Th17 transcriptional programs (Lazarevic et al., 2013) . The importance of T-bet in EAE and MS pathogenesis was initially postulated based on the understanding that Th1 cells mediate pathological neuroinflammation (Segal, 2003; Martin and Mcfarland, 1995) . The subsequent discovery that Th17 cells could also drive EAE initially appeared to pose a paradox. However, Th17 cells are plastic and acquire Th1-like characteristics following restimulation with IL-23 by a T-bet dependent pathway (Lee et al., 2009 ). In fact, fate mapping studies have shown that the majority of CD4 + T cells isolated from the CNS at peak EAE are Th17 cells that have upregulated T-bet and IFNγ, and downregulated RORγt and IL-17 (referred to as ex-Th17 cells) (Hirota et al., 2011; Kurschus et al., 2010) . We have previously demonstrated that, although stable myelin-specific Th17 cell can transfer EAE independently of T-bet, they are significantly less potent than T-bet expressing exTh17 cells (Carbajal et al., 2015; Grifka-Walk et al., 2013) . Since IFNγ is dispensable for the manifestation of clinical EAE (Kroenke et al., 2008 (Kroenke et al., , 2010 Ferber et al., 1996) , the pathway employed by T-bet to promote encephalitogenicity in exTh17 cells remains to be elucidated. Here, we investigated the mechanism of action of T-bet by comparing the fates of T-bet deficient and wild-type MOG-specific CD4 + Th17 cells following adoptive transfer, either together or in parallel, into RAG2 −/− hosts. Our findings suggest that T-bet facilitates the selective trafficking of CD4 + T cells to the CNS, likely by regulating cell surface expression of adhesion molecules and chemokine receptors.
Materials and methods

Mice
8-12-wk.-old C57BL/6 CD45.1 congenic (B6·SJL-Ptprca Pepcb/BoyJ), T-bet −/− and RAG2 −/− mice were obtained from the Jackson Laboratory and housed in microisolator cages under specific pathogen-free conditions. T-bet −/− and RAG2 −/− mice were subsequently bred in our 
